Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by R R Furman
Extended Follow-Up and Impact of High-Risk Prognostic Factors From the Phase 3 RESONATE Study in Patients With Previously Treated CLL/SLL
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
MicroRNA-155 Regulates Casein Kinase 1 Gamma 2: A Potential Pathogenetic Role in Chronic Lymphocytic Leukemia
Blood Cancer Journal
Oncology
Hematology
Related publications
Patterns of Duvelisib-Induced Lymphocytosis in Patients With R/R CLL or SLL Including Those With High-Risk Factors Treated in the Duo Trial
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Ibrutinib Versus Temsirolimus: 3-Year Follow-Up of Patients With Previously Treated Mantle Cell Lymphoma From the Phase 3, International, Randomized, Open-Label RAY Study
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Long-Term Follow-Up of the RESONATE™ Phase 3 Trial of Ibrutinib Versus Ofatumumab
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Predictors of Sudden Cardiac Death in Never Previously Treated Patients With Essential Hypertension: Long-Term Follow-Up
Journal of Human Hypertension
Internal Medicine
Extended Follow-Up of Treated and Untreated Retinopathy in Incontinentia Pigmenti
JAMA Ophthalmology
Ophthalmology
Risk Factors for Fall in Elderly Patients: Follow-Up Study After Hospital Discharge
Open Journal of Internal Medicine
Prognostic Factors for Patients Treated With Abiraterone
Future Science OA
Medicine
Biotechnology
Risk for High Depressive Symptoms in Diagnosed and Previously Undetected Diabetes: 5-Year Follow-Up Results of the Heinz Nixdorf Recall Study
PLoS ONE
Multidisciplinary
Atezolizumab in Japanese Patients With Previously Treated, Advanced Non–small-Cell Lung Cancer: A Subgroup Analysis of the Phase 3 OAK Study
Clinical Lung Cancer
Cancer Research
Oncology
Respiratory Medicine
Pulmonary
